Study of alanine-73 and aspartate-9 of HLA-C locus in Saudi psoriasis patients, using sequence-specific primers (PCR-SSP).

Alanine at residue 73 (Ala-73) and aspartate at residue 9 (Asp-9) are characteristic to both Cw6 and Cw7 alleles of HLA-C gene and have been suggested as possible markers for psoriasis vulgaris (PsV). However, the results from various ethnic groups/populations are contradictory and inconclusive. In this study, an attempt has been made to examine the association between HLA-C (Ala-73 and Asp-9) and susceptibility to PsV among Saudi patients. Genomic DNA was extracted from 25 Saudi PsV patients and 75 control subjects. Polymerase chain reaction (PCR) was performed to amplify HLA-C sequences using earlier reported primers, C133P and C243PR. Sequence-specific primers were used to specifically detect nucleotide coding for Ala-73 and Asp-9 in all the subjects. The results showed significantly higher frequency of Asp-9 (84.0 % versus 61.3 %) in PsV patients as compared to controls (p < 0.05, 2-tailed Fisher's exact test). The frequencies of Ala-73 among PsV patients (92 %) and controls (88 %) did not differ significantly.

[1]  J. Gulcher,et al.  HLA-Cw6-positive and HLA-Cw6-negative patients with Psoriasis vulgaris have distinct clinical features. , 2002, The Journal of investigative dermatology.

[2]  M. Fatani,et al.  Psoriasis in the eastern Saudi Arabia. , 2002, Saudi medical journal.

[3]  L. Samuelsson,et al.  Stronger association with HLA-Cw6 than with corneodesmosin (S-gene) polymorphisms in Swedish psoriasis patients , 2000, Archives of Dermatological Research.

[4]  P. Stastny,et al.  Role of HLA-B and C alleles in development of psoriasis in patients from North India. , 1998, Tissue antigens.

[5]  M. Bunce,et al.  HLA-CW*0602 is a susceptibility factor in type I psoriasis, and evidence Ala-73 is increased in male type I psoriatics. , 1997, The Journal of investigative dermatology.

[6]  C. Enerbäck,et al.  Evidence that HLA-Cw6 determines early onset of psoriasis, obtained using sequence-specific primers (PCR-SSP). , 1997, Acta dermato-venereologica.

[7]  H. Nakagawa,et al.  Study of aspartate at residue 9 of HLA-C molecules in Japanese patients with psoriasis vulgaris. , 1996, Journal of dermatological science.

[8]  J. Karvonen,et al.  HLA risk haplotype Cw6,DR7, DQA1*0201 and HLA-Cw6 with reference to the clinical picture of psoriasis vulgaris , 1996, Archives of Dermatological Research.

[9]  W. Thomson,et al.  Definition of HLA-C alleles using sequence-specific oligonucleotide probes (PCR-SSOP). , 1995, Tissue antigens.

[10]  I. Jónsdóttir,et al.  Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens? , 1995, Immunology today.

[11]  K. Tokunaga,et al.  Do specific pockets of HLA-C molecules predispose Jewish patients to psoriasis vulgaris? , 1994, Journal of the American Academy of Dermatology.

[12]  J. Karvonen,et al.  Alanine at position 73 of HLA‐C is associated with psoriasis vulgaris in Finland , 1994, The British journal of dermatology.

[13]  J. Hansen,et al.  Molecular diversity of the HLA-C locus in unrelated marrow transplantation. , 1994, Tissue antigens.

[14]  C. Eastmond.  Genetics and HLA antigens , 1994 .

[15]  P. Parham,et al.  Distinctive polymorphism at the HLA-C locus: implications for the expression of HLA-C , 1992, The Journal of experimental medicine.

[16]  S. Akazaki,et al.  Specific nucleotide sequence of HLA-C is strongly associated with psoriasis vulgaris. , 1991, The Journal of investigative dermatology.

[17]  S. Akazaki,et al.  Association of Cw11 in Japanese patients with psoriasis vulgaris. , 1990, Tissue antigens.

[18]  A. Gottlieb,et al.  HLA region genes and immune activation in the pathogenesis of psoriasis. , 1990, Archives of dermatology.

[19]  M. A. Saper,et al.  Specificity pockets for the side chains of peptide antigens in HLA-Aw68 , 1990, Nature.

[20]  H. Inoko,et al.  Specific restriction fragment length polymorphism on the HLA-C region and susceptibility to psoriasis vulgaris. , 1988, The Journal of investigative dermatology.

[21]  J. Karvonen,et al.  Psoriasis and HLA‐Cw6 , 1980, The British journal of dermatology.

[22]  D. Wiley,et al.  Structure of the human class I histocompatibility antigen, HLA-A2. , 2005, Journal of immunology.

[23]  M. Bunce,et al.  Rapid DNA typing for HLA-C using sequence-specific primers (PCR-SSP): identification of serological and non-serologically defined HLA-C alleles including several new alleles. , 1994, Tissue antigens.

[24]  C. Eastmond.  Psoriatic arthritis. Genetics and HLA antigens. , 1994, Bailliere's clinical rheumatology.